Literature DB >> 145872

Intense tumour-cell destruction by syngeneic mice: role of macrophages, complement activation and tumour-cell factors.

S Orbach-Arbouys, J Lheritier, M Allouche, P Pouillart.   

Abstract

When injected i.p. and in large numbers (10(7)) into syngeneic mice, 125IUdR-labelled L1210 cells are rapidly destroyed in a small proportion of animals, while in the other animals the lysis is low. This bimodal distribution is clearly visible 24 h after cell injection. The intense lysis occurs in fewer animals when macrophage-derived lysosomal enzymes are inhibited by trypan blue and if the complement is depleted by high doses of cobra venom factor (CVF). The intense destruction occurs in more animals after adjuvant treatment, if the mice are latently contaminated, after a moderate production of C3b by low doses of CVF, or after the injection of a tumour-cell dialysate. The destruction seems to be the result of positive feedback reaction which involves at least macrophages and complement activation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 145872      PMCID: PMC2025552          DOI: 10.1038/bjc.1977.257

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  In vitro tumor cell destruction by syngeneic mouse macrophoages: methods for assaying cytotoxicity.

Authors:  K C Norbury; I J Fidler
Journal:  J Immunol Methods       Date:  1975-04       Impact factor: 2.303

2.  Activated macrophages as cytotoxic effector cells.

Authors:  J B Hibbs
Journal:  Transplantation       Date:  1975-01       Impact factor: 4.939

3.  Anti-tumour antibodies in normal mouse sera.

Authors:  S E Martin; W J Martin
Journal:  Int J Cancer       Date:  1975-04-15       Impact factor: 7.396

4.  Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance.

Authors:  J B Hibbs; L H Lambert; J S Remington
Journal:  Nat New Biol       Date:  1972-01-12

5.  The kinetics of the killing of mouse tumour cells in vivo by immune responses.

Authors:  D D Porteous; T R Munro
Journal:  Int J Cancer       Date:  1972-07-15       Impact factor: 7.396

6.  In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages.

Authors:  C Bentley; D Bitter-Suermann; U Hadding; V Brade
Journal:  Eur J Immunol       Date:  1976-06       Impact factor: 5.532

7.  Natural anti-tumor serum reactivity in BALB/c mice. I. Characterization and interference with tumor growth.

Authors:  S Ménard; M I Colnaghi; G D Porta
Journal:  Int J Cancer       Date:  1977-02-15       Impact factor: 7.396

8.  Natural antibodies directed against murine lymphosarcoma cells.

Authors:  M A Pierotti; M I Colnaghi
Journal:  J Natl Cancer Inst       Date:  1975-10       Impact factor: 13.506

9.  Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance.

Authors:  M C Pike; R Snyderman
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

10.  Trapping and destruction of blood-borne syngeneic leukaemia cells in lung, liver and spleen of normal and leukaemic rats.

Authors:  T E Sadler; P Alexander
Journal:  Br J Cancer       Date:  1976-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.